Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis

• Main Authors: Yuan-Kun (Aden) (Author), An-Li Yu (Author), Mei-Fang Cheng (Author), Lung-Chun Lin (Author), Ming-Jen Lee (Author), Chia-Hung Chou (Author), Chia-Tung Shun (Author), Hsueh-Wen Hsueh (Author), Jimmy Jyh-Ming Juang (Author), Ping-Huei Tseng (Author), Siao-Ping Lin (Author), Mao-Yuan Su (Author), Chi-Chao Chao (Author), Sung-Tsang Hsieh (Author), Cheng-Hsuan Tsai (Author), Yen-Hung Lin (Author)
• Formato: Libro
• Publicado: SAGE Publishing, 2024-01-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Background: Transthyretin cardiomyopathy (ATTR-CM) is a debilitating disease that has received much attention since the emergence of novel treatments. The Transthyretin Cardiomyopathy Clinical Trial showed that tafamidis, a transthyretin tetramer stabilizer, effectively reduced the declines in funct...